Onkure Therapeutics, Inc. · NASDAQ:OKUR
Trails Edge Capital Partners, LP reported a 6.00% stake in Onkure Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 7, 2026
Trails Edge Capital Partners, LP reported a 6.00% stake in Onkure Therapeutics, Inc., 2,409,638 shares, as a passive investor on Mar 31, 2026. Filed Apr 7, 2026 (Schedule 13G).
- Stake
- 6.00%
- Shares
- 2,409,638
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Trails Edge Capital Partners, LP | 6.00% | 2,409,638 |
| Trails Edge Biotechnology Master Fund, LP | 6.00% | 2,409,638 |
| Ortav Yehudai | 6.00% | 2,409,638 |
Source
Related
- Onkure Therapeutics, Inc.
- Trails Edge Capital Partners, LP
- Onkure Therapeutics, Inc. shareholders
- Schedule 13G · Coastlands Capital LP · Oct 7, 2026
- Form 4 · Saccomano Nicholas A · Sep 23, 2026
- Form 4 · Leverone Jason A. · Sep 23, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026